E
ChitogenX Inc.
CHNXF
$0.0071
-$0.0039-35.46%
E
Sell
2/5/2025Upgraded
ChitogenX Inc. (CHNXF) was upgraded to E+ from E on 2/5/2025 due to an increase in the volatility index, total return index and growth index.
ChitogenX Inc. (CHNXF) was upgraded to E+ from E on 2/5/2025 due to an increase in the volatility index, total return index and growth index.
E
Sell
1/21/2025Downgrade
ChitogenX Inc. (CHNXF) was downgraded to E from E+ on 1/21/2025 due to a decline in the volatility index.
ChitogenX Inc. (CHNXF) was downgraded to E from E+ on 1/21/2025 due to a decline in the volatility index.
E
Sell
1/6/2025Upgraded
ChitogenX Inc. (CHNXF) was upgraded to E+ from E on 1/6/2025 due to an increase in the volatility index.
ChitogenX Inc. (CHNXF) was upgraded to E+ from E on 1/6/2025 due to an increase in the volatility index.
E
Sell
8/20/2024Downgrade
ChitogenX Inc. (CHNXF) was downgraded to E from E+ on 8/20/2024 due to a noticeable decline in the solvency index, total return index and volatility index.
ChitogenX Inc. (CHNXF) was downgraded to E from E+ on 8/20/2024 due to a noticeable decline in the solvency index, total return index and volatility index.
E
Sell
8/5/2024Upgraded
ChitogenX Inc. (CHNXF) was upgraded to E+ from E on 8/5/2024 due to an increase in the volatility index and valuation index.
ChitogenX Inc. (CHNXF) was upgraded to E+ from E on 8/5/2024 due to an increase in the volatility index and valuation index.
E
Sell
7/2/2024Downgrade
ChitogenX Inc. (CHNXF) was downgraded to E from E+ on 7/2/2024 due to a decline in the volatility index, total return index and valuation index.
ChitogenX Inc. (CHNXF) was downgraded to E from E+ on 7/2/2024 due to a decline in the volatility index, total return index and valuation index.
E
Sell
6/14/2024Upgraded
ChitogenX Inc. (CHNXF) was upgraded to E+ from E on 6/14/2024 due to an increase in the growth index, volatility index and total return index. Operating cash flow increased 68.97% from -$217.2 to -$67.4, and earnings per share increased from -$0.0072 to -$0.0041.
ChitogenX Inc. (CHNXF) was upgraded to E+ from E on 6/14/2024 due to an increase in the growth index, volatility index and total return index. Operating cash flow increased 68.97% from -$217.2 to -$67.4, and earnings per share increased from -$0.0072 to -$0.0041.
E
Sell
6/5/2024Downgrade
ChitogenX Inc. (CHNXF) was downgraded to E from E+ on 6/5/2024 due to a noticeable decline in the volatility index, total return index and solvency index. The quick ratio declined from 0.07 to 0.06, and debt to equity increased from -0.61 to -0.6.
ChitogenX Inc. (CHNXF) was downgraded to E from E+ on 6/5/2024 due to a noticeable decline in the volatility index, total return index and solvency index. The quick ratio declined from 0.07 to 0.06, and debt to equity increased from -0.61 to -0.6.
E
Sell
3/16/2023Downgrade
ChitogenX Inc. (CHNXF) was downgraded to E+ from D- on 3/16/2023 due to a decline in the volatility index and total return index.
ChitogenX Inc. (CHNXF) was downgraded to E+ from D- on 3/16/2023 due to a decline in the volatility index and total return index.
D
Sell
2/23/2023Upgraded
ChitogenX Inc. (CHNXF) was upgraded to D- from E+ on 2/23/2023 due to an increase in the volatility index and total return index.
ChitogenX Inc. (CHNXF) was upgraded to D- from E+ on 2/23/2023 due to an increase in the volatility index and total return index.
E
Sell
2/8/2023Downgrade
ChitogenX Inc. (CHNXF) was downgraded to E+ from D- on 2/8/2023 due to a noticeable decline in the solvency index and valuation index. The quick ratio declined from 0.22 to 0.06, and debt to equity increased from -0.97 to -0.8.
ChitogenX Inc. (CHNXF) was downgraded to E+ from D- on 2/8/2023 due to a noticeable decline in the solvency index and valuation index. The quick ratio declined from 0.22 to 0.06, and debt to equity increased from -0.97 to -0.8.
D
Sell
5/23/2022Upgraded
Ortho Regenerative Technologies Inc. (ORTIF) was upgraded to D- from E+ on 5/23/2022 due to an increase in the growth index. Earnings per share increased from -$0.0439 to -$0.0193.
Ortho Regenerative Technologies Inc. (ORTIF) was upgraded to D- from E+ on 5/23/2022 due to an increase in the growth index. Earnings per share increased from -$0.0439 to -$0.0193.
E
Sell
3/21/2022Downgrade
Ortho Regenerative Technologies Inc. (ORTIF) was downgraded to E+ from D- on 3/21/2022 due to a decline in the total return index and volatility index.
Ortho Regenerative Technologies Inc. (ORTIF) was downgraded to E+ from D- on 3/21/2022 due to a decline in the total return index and volatility index.
D
Sell
12/23/2021Downgrade
Ortho Regenerative Technologies Inc. (ORTIF) was downgraded to D- from D on 12/23/2021 due to a large decline in the growth index, solvency index and total return index. Earnings per share declined from -$0.0211 to -$0.0439, the quick ratio declined from 3.14 to 0.6, and EBIT declined 69.44% from -$465.3 to -$788.4.
Ortho Regenerative Technologies Inc. (ORTIF) was downgraded to D- from D on 12/23/2021 due to a large decline in the growth index, solvency index and total return index. Earnings per share declined from -$0.0211 to -$0.0439, the quick ratio declined from 3.14 to 0.6, and EBIT declined 69.44% from -$465.3 to -$788.4.
D
Sell
11/3/2021Upgraded
Ortho Regenerative Technologies Inc. (ORTIF) was upgraded to D from D- on 11/3/2021 due to an increase in the growth index, solvency index and volatility index. The quick ratio increased from 0.59 to 3.14, EBIT increased 35.14% from -$717.4 to -$465.3, and earnings per share increased from -$0.0283 to -$0.0211.
Ortho Regenerative Technologies Inc. (ORTIF) was upgraded to D from D- on 11/3/2021 due to an increase in the growth index, solvency index and volatility index. The quick ratio increased from 0.59 to 3.14, EBIT increased 35.14% from -$717.4 to -$465.3, and earnings per share increased from -$0.0283 to -$0.0211.
D
Sell
7/1/2021Upgraded
Ortho Regenerative Technologies Inc. (ORTIF) was upgraded to D- from E on 7/1/2021 due to a large increase in the solvency index, growth index and valuation index. Operating cash flow increased 15.25% from -$768.4 to -$651.2, EBIT increased 5.23% from -$756.8 to -$717.2, and earnings per share increased from -$0.0286 to -$0.0283.
Ortho Regenerative Technologies Inc. (ORTIF) was upgraded to D- from E on 7/1/2021 due to a large increase in the solvency index, growth index and valuation index. Operating cash flow increased 15.25% from -$768.4 to -$651.2, EBIT increased 5.23% from -$756.8 to -$717.2, and earnings per share increased from -$0.0286 to -$0.0283.
E
Sell
5/19/2021Downgrade
Ortho Regenerative Technologies Inc. (ORTIF) was downgraded to E from E+ on 5/19/2021 due to a decline in the volatility index and valuation index.
Ortho Regenerative Technologies Inc. (ORTIF) was downgraded to E from E+ on 5/19/2021 due to a decline in the volatility index and valuation index.
E
Sell
5/4/2021Upgraded
Ortho Regenerative Technologies Inc. (ORTIF) was upgraded to E+ from E on 5/4/2021 due to an increase in the volatility index and valuation index.
Ortho Regenerative Technologies Inc. (ORTIF) was upgraded to E+ from E on 5/4/2021 due to an increase in the volatility index and valuation index.
E
Sell
4/16/2021Downgrade
Ortho Regenerative Technologies Inc. (ORTIF) was downgraded to E from E+ on 4/16/2021 due to a decline in the volatility index.
Ortho Regenerative Technologies Inc. (ORTIF) was downgraded to E from E+ on 4/16/2021 due to a decline in the volatility index.
E
Sell
4/1/2021Upgraded
Ortho Regenerative Technologies Inc. (ORTIF) was upgraded to E+ from E on 4/1/2021 due to an increase in the total return index and volatility index.
Ortho Regenerative Technologies Inc. (ORTIF) was upgraded to E+ from E on 4/1/2021 due to an increase in the total return index and volatility index.
E
Sell
3/31/2021Upgraded
Ortho Regenerative Technologies Inc. (ORTIF) was upgraded to E from E- on 3/31/2021 due to an increase in the volatility index.
Ortho Regenerative Technologies Inc. (ORTIF) was upgraded to E from E- on 3/31/2021 due to an increase in the volatility index.
E
Sell
3/16/2021Downgrade
Ortho Regenerative Technologies Inc. (ORTIF) was downgraded to E- from E on 3/16/2021 due to a major decline in the volatility index.
Ortho Regenerative Technologies Inc. (ORTIF) was downgraded to E- from E on 3/16/2021 due to a major decline in the volatility index.
E
Sell
12/30/2020None
ChitogenX Inc. (CHNXF) was downgraded to E from U on 12/30/2020.
ChitogenX Inc. (CHNXF) was downgraded to E from U on 12/30/2020.
OTC PK
02/19/2025 10:14AM Eastern
Quotes delayed
